Apolipoprotein (APOE) ɛ4 is an established genetic risk factor for late-onset AD [23, 24] and has been shown to influence not only the age of onset and rate of progression, but also the clinical phenotype [25–27]. The gene discussed is APOE; the disease is Alzheimer disease.